Hims & Hers Health, Inc. (NYSE:HIMS) shares are trading 16% higher Wednesday, adding to gains of more than 35% over the past month. Here’s a look at what’s going on.
What To Know: In late June, shares initially traded lower but later bounced back after Novo Nordisk announced it would no longer be working with Hims & Hers. Because of this, the company will lose direct access to Wegovy via the NovoCare Pharmacy.
